INTERCEPT PHARMACEUTICALS, INC. Insider Trading for November 2019

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for November 2019.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM58.741066,2262,989
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM59.124,267252,26518,983
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM58.741056,1683,095
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Option ExerciseM59.121,750103,46023,250
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS100.004,373437,30015,75920.1 K to 15.8 K (-21.72 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM58.741066,22620,13220 K to 20.1 K (+0.53 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM59.124,267252,26520,02615.8 K to 20 K (+27.08 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS100.001,855185,50015,75917.6 K to 15.8 K (-10.53 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM58.741056,16817,61417.5 K to 17.6 K (+0.60 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...BuyM59.121,750103,46017,50915.8 K to 17.5 K (+11.10 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOOption ExerciseM21.5015,557334,47630,601
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOOption ExerciseM8.6719,880172,2940
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOOption ExerciseM8.6714,524125,87519,880
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOOption ExerciseM8.67393380
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOSellS100.0035,4373,543,700469,126504.6 K to 469.1 K (-7.02 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOBuyM21.5015,557334,476504,563489 K to 504.6 K (+3.18 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOBuyM8.6719,880172,294489,006469.1 K to 489 K (+4.24 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOSellS100.0014,5631,456,300469,126483.7 K to 469.1 K (-3.01 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOBuyM8.6714,524125,875483,689469.2 K to 483.7 K (+3.10 %)
Nov 27 2019ICPTINTERCEPT PHARMACE ...Pruzanski MarkPresident & CEOBuyM8.6739338469,165469.1 K to 469.2 K (+0.01 %)
Nov 26 2019ICPTINTERCEPT PHARMACE ...Durso Jerome BenedictChief Operating Off ...Payment of ExerciseF88.8946040,88931,81232.3 K to 31.8 K (-1.43 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.001,550131,75015,75917.3 K to 15.8 K (-8.95 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.001,550131,75015,75917.3 K to 15.8 K (-8.95 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseM53.418,325444,63826,475
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseM53.418,325444,63826,475
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.003,829325,46521,88925.7 K to 21.9 K (-14.89 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.003,829325,46521,88925.7 K to 21.9 K (-14.89 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.008,325707,62525,71834 K to 25.7 K (-24.45 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.008,325707,62525,71834 K to 25.7 K (-24.45 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...BuyM53.418,325444,63834,04325.7 K to 34 K (+32.37 %)
Nov 19 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...BuyM53.418,325444,63834,04325.7 K to 34 K (+32.37 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Option ExerciseM53.4150026,70534,800
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF83.9271159,66725,71826.4 K to 25.7 K (-2.69 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...SellS85.0050042,50026,42926.9 K to 26.4 K (-1.86 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...BuyM53.4150026,70526,92926.4 K to 26.9 K (+1.89 %)
Nov 15 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...SellS85.0094680,41017,30918.3 K to 17.3 K (-5.18 %)
Nov 14 2019ICPTINTERCEPT PHARMACE ...Cawkwell GailSVP, Med Affairs, S ...Payment of ExerciseF83.0231926,48318,64219 K to 18.6 K (-1.68 %)
Nov 12 2019ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF82.7612810,59311,26811.4 K to 11.3 K (-1.12 %)

Contact us | Follow us on Twitter